A detailed history of Mather Group, Llc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 169 shares of BIO stock, worth $54,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169
Previous 360 53.06%
Holding current value
$54,132
Previous $98,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$263.97 - $344.64 $50,418 - $65,826
-191 Reduced 53.06%
169 $56,000
Q2 2024

Jul 08, 2024

BUY
$268.26 - $339.48 $26,826 - $33,948
100 Added 38.46%
360 $98,000
Q1 2024

Apr 08, 2024

BUY
$304.11 - $351.99 $79,068 - $91,517
260 New
260 $89,000
Q1 2023

May 09, 2023

BUY
$418.69 - $503.0 $1,256 - $1,509
3 Added 0.58%
520 $249,000
Q4 2022

Mar 10, 2023

BUY
$351.71 - $456.01 $181,834 - $235,757
517 New
517 $217,000
Q2 2022

Aug 16, 2022

BUY
$463.67 - $597.16 $20,401 - $26,275
44 Added 11.67%
421 $208,000
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $12,589 - $17,650
24 Added 6.8%
377 $212,000
Q4 2021

Feb 15, 2022

SELL
$708.84 - $794.68 $10,632 - $11,920
-15 Reduced 4.08%
353 $267,000
Q3 2021

Nov 04, 2021

SELL
$657.71 - $825.77 $13,154 - $16,515
-20 Reduced 5.15%
368 $275,000
Q2 2021

Aug 13, 2021

SELL
$576.64 - $649.04 $2,883 - $3,245
-5 Reduced 1.27%
388 $250,000
Q1 2021

May 14, 2021

BUY
$547.01 - $662.35 $547 - $662
1 Added 0.26%
393 $224,000
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $1,532 - $1,930
3 Added 0.77%
392 $229,000
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $176,773 - $208,348
389 New
389 $201,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.